☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
TIDES
Takeda Reports Long-Term Safety and Efficacy Results of its Dengue Vaccine Candidate
May 24, 2021
Takeda Reports Results of TAK-003 in P-III TIDES (DEN-301) Trial for Dengue
January 30, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.